Sparian Biosciences

About:

Sparian Biosciences is a biopharmaceutical company.

Website: https://www.sparianbiosciences.com

Top Investors: National Institutes of Health, National Institute on Drug Abuse (NIDA)

Description:

Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique, transformative medicines for the central nervous system. They develop therapeutics targeting the brain through innovative science and novel drug discovery.

Total Funding Amount:

$19.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New York, New York, United States

Founded Date:

2018-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-11-14

IPO Status:

Private

Industries: